Jury Awards $12.2M To Surgery Tube Co. In False Ad Row
Law360, New York (April 12, 2017, 6:24 PM EDT) -- A Delaware federal jury awarded $12.2 million on Tuesday to surgery-device maker Lexion Medical LLC, including $10 million in punitive damages, agreeing with Lexion that rival SurgiQuest Inc. committed false advertising in their fight over tubes used in laparoscopic procedures.
SurgiQuest had sued Lexion in Delaware federal court in March 2014 in connection with a SurgiQuest laparoscopy system called AirSeal. Lexion's rival devices are called Insuflow and Synergy. All three devices facilitate the injection of gas into a patient's body between the abdominal wall and the organs that are being worked on, which gives the surgeon more maneuvering room.
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!